SUBSCRIBE
SUBSCRIBE
News   Business

BioAlliance Pharma Announces Its Consolidated Turnover for 2009 a Doubling in Recurring Revenues

February 9, 2010 | 
1 min read
PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced a turnover of of €7.5 million for 2009.
Earnings Europe
MORE ON THIS TOPIC
Vector cartoon illustration of a business team standing at a crossroad with multiple arrows, discussing and choosing the right path toward success and future opportunities.
Drug pricing
Drugmakers cherry pick launch regions as MFN creates ‘policy environment like an earthquake’
September 10, 2026
 · 
4 min read
 · 
Annalee Armstrong
A pay raise signals salary increase, income growth, rising investment profits and earnings, along with career development and wealth management, concept of A jubilant businessman jumping atop a growing stack of money coins
Funding
Encoded raises $275M series F for Dravet syndrome gene therapy
September 10, 2026
 · 
2 min read
 · 
Tristan Manalac
Illustration of dark room opening into outdoors with sun peeking out
Layoffs
August biopharma layoffs impact just over 500, down 90% year over year
September 10, 2026
 · 
6 min read
 · 
Angela Gabriel
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Merck adds 53 to New Jersey chopping block
September 9, 2026
 · 
91 min read
 · 
BioSpace Editorial Staff